A population pharmacokinetic-pharmacodynamic model of navtemadlin, its glucuronide metabolite (M1) and serum macrophage inhibitory cykokine-1 (MIC-1)

Saved in:
Bibliographic Details
Published inXenobiotica Vol. 52; no. 6; pp. 555 - 566
Main Authors Zhang, Lu, Poland, Bill, Green, Michelle, Wong, Shekman, Slatter, J. Greg
Format Journal Article
LanguageEnglish
Published Taylor & Francis 03.06.2022
Subjects
enterohepatic recirculation
GDF15
KRT-232
MDM2 inhibitor
MIC-1
navtemadlin
pharmacodynamics
pharmacokinetics
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0049-8254
1366-5928
DOI:10.1080/00498254.2022.2114116